Hosted on MSN6mon
Why Jennifer Doudna is one of Fast Company’s 10 most innovative people of the last 10 years
When biochemist Jennifer Doudna and her research partner, Emmanuelle Charpentier, published a paper in Science 12 years ago, they had a hunch that their findings would transform how genomics is ...
The Times of Israel on MSN16d
Israeli researchers use gene editing to eliminate 50% of head, neck tumors in mice
Tel Aviv University scientists say that they can inject CRISPR genetic 'molecular scissors' to shrink tumors by 90%; researcher 'optimistic' about clinical trials in 2 to 3 years The post Israeli ...
University of California12d
Discoveries that changed the world: Meet UC’s women Nobel laureates
If Andrea Ghez had listened to her critics, one of the galaxy’s greatest mysteries might yet remain unsolved. The UCLA ...
Local News Matters on MSN23d
Changing the climate on science: Nationwide movement pushes back on cuts for research
So, let’s fight back with science, but with humanity too.” Nobel Laureate Jennifer Doudna is the Li Ka Shing chancellor’s ...
The Scientist4y
CRISPR’s Adaptation to Genome Editing Earns Chemistry Nobel
Emmanuelle Charpentier and Jennifer Doudna reprogrammed the bacterial immune response into one of the most popular tools for genetics and molecular biology. Amanda was an associate editor at The ...
KQED25d
UC Berkeley Scientists Protest Trump Administration’s Cuts to Research Funding
Jennifer Doudna speaks at a rally at UC Berkeley in association with the national Stand Up for Science day of action in Berkeley on March 7, 2025. (Martin do Nascimento/KQED) NIH, the largest ...
The Scientist5mon
From CRISPR to Prime Editing: The Evolution of the Genome Editing Revolution
Scientists realized that they could edit and disrupt gene ... it may also lead to unintended chromosomal loss in the edited immune cells. Biochemist Jennifer Doudna and her team at the University of ...
Hosted on MSN1mon
Tempus AI director Jennifer Doudna sells $118,800 in stock
Jennifer Doudna, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold a portion of her holdings in the company. According to a recent SEC filing, Doudna sold 1,320 shares of Tempus AI's ...